Novavax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,332	1,288	570	884	10,817	4,079
Market Cap Growth	-5.85%	125.87%	-35.49%	-91.83%	165.21%	4270.56%
Enterprise Value	801	641	178	300	9,339	4,230
Last Close Price	7.87	8.04	4.80	10.28	143.07	111.51
Forward PE	-	-	-	-	10.46	10.88
PS Ratio	1.19	1.89	0.58	0.45	9.44	8.58
PB Ratio	-	-2.06	-0.79	-1.39	-30.76	6.50
P/TBV Ratio	-	-	-	-	-	8.39
P/FCF Ratio	-	-	-	-	40.30	-
P/OCF Ratio	-	-	-	-	33.50	-
EV/Sales Ratio	0.75	0.94	0.18	0.15	8.15	8.90
EV/FCF Ratio	-	-	-	-	34.79	-
Debt / Equity Ratio	-1.60	-0.42	-0.39	-0.97	-1.49	0.77
Debt / FCF Ratio	-	-	-	-	1.95	-
Asset Turnover	0.74	0.41	0.49	0.82	0.55	0.54
Inventory Turnover	39.01	22.59	26.47	90.94	-	-
Quick Ratio	1.85	0.89	0.53	0.58	0.82	1.68
Current Ratio	2.27	0.98	0.70	0.69	0.90	2.15
Return on Equity (ROE)	-	-	-	-	-1265.71%	-189.60%
Return on Assets (ROA)	18.01%	-8.63%	-17.02%	-16.67%	-50.69%	-29.48%
Return on Capital Employed (ROCE)	55.60%	-57.10%	-340.10%	320.30%	-904.70%	-41.30%
Earnings Yield	26.03%	-14.56%	-95.59%	-74.44%	-16.12%	-10.25%
FCF Yield	-29.23%	-7.79%	-134.64%	-57.14%	2.48%	-2.38%
Buyback Yield / Dilution	-16.16%	-51.03%	-28.89%	-5.08%	-29.27%	-138.81%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q